Meta-analysis on Efficacy and Safety of Compound Banmao Capsules Combined with Chemotherapy in Elderly Patients with Advanced Gastric Cancer Click Copy

Meta-analysis on Efficacy and Safety of Compound Banmao Capsules Combined with Chemotherapy in Elderly Patients with Advanced Gastric Cancer

References:

[1] BRAY F, FERLAY J, SOERJOMATARAM I, et al. Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018,68(6):394424.

[2] 2018年全国最新癌症报告:每分钟有7人被确诊为癌症[J].新民周刊, 2018(14):53.

[3] ZHU L, LIU J, MA S. Fluoropyrimidine-based chemotherapy as first-line treatment for advanced gastric cancer:a Bayesian network meta-analysis [J]. Pathol Oncol Res,2016,22(4):853-861.

[4] RAUH R, KAHL S, BOECHZELT H, et al. Molecular biology of cantharidin in cancer cells[J]. Chin Med,2007,2(1):8.

[5] THERASSE P, ARBUCK S G, EISENHAUER E A, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada[J]. J Natl Cancer Inst,2000,92(3):205-216.

[6] 杨学宁,吴一龙.实体瘤治疗疗效评价标准-RECIST[J].循证医学, 2004,4(2):85-90,111.

[7] HIGGINS J P T, GREEN S. Cochrane handbook for systematic reviews of interventions version 5.1.0(2011-03)[M/OL]. The Cochrane Collaboration[2019-06-20].2011.http://www.cochrane-handbook.org.

[8] 王海英,汤虹,周孟强,等.SOX化疗方案联合复方斑蝥胶囊治疗老年晚期胃癌的效果[J].中国老年学杂志,2018,38(1):142-144.

[9] 邢艳丽.复方斑蝥胶囊联合FOLFOX6方案对老年晚期胃癌患者无进展生存期的影响[J].现代医用影像学,2018,27(7):2469-2470.

[10] 彭子云.复方斑蝥胶囊联合SOX化疗方案治疗老年晚期胃癌患者的临床效果[J].河南医学研究,2019,28(4):703-704.

[11] 谭扬,赵福友,吴穷.复方斑蝥胶囊联合化疗治疗老年晚期胃癌的疗效[J].重庆医学,2013,42(4):393-395.

[12] 李莹,王季堃,李巍.复方斑蝥胶囊联合化疗治疗老年晚期胃癌的疗效观察[J].中国实用医药,2017,12(10):115-117.

[13] 朱桂平.复方斑蝥胶囊联合化疗治疗老年晚期胃癌的疗效观察[J].中国医药指南,2016,14(2):178-179.

[14] 吴金成.复方斑蝥胶囊联合化疗治疗老年晚期胃癌疗效观察[J].光明中医,2015,30(12):2642-2643.

[15] 关素珍,王斌,郭磊,等.复方斑蝥胶囊治疗老年晚期胃癌的临床研究[J].时珍国医国药,2014,25(12):2960-2961.

[16] 夏恪迪,张赢予,张馨木,等.复方斑蝥胶囊体内抗肿瘤作用的实验研究[J].中国药业,2007,16(15):13-14.

[17] 曾瑶波,刘晓玲,李创军,等.斑蝥化学成分及体外抗肿瘤活性研究[J].中国中药杂志,2016,41(5):859-863.

[18] 吴晓龙,崔思远,王琰,等.中药半枝莲有效成分抗肿瘤作用机制研究进展[J].中华中医药杂志,2018,33(4):1459-1462.

[19] 高彦宇,李文慧,寇楠,等.刺五加化学成分和药理作用研究进展[J].中医药信息,2019,36(2):113-116.

[20] 祁元刚,孙利国.黄芪抗肿瘤机制研究进展[J].新中医,2018,50(9):34-36.

[21] 王柳春,孙慧,李凯.黄芪多糖与粒细胞集落刺激因子对化疗后骨髓功能的影响[J].中国肿瘤临床,2008,35(23):1373-1376.

[22] 魏朝辉,张文军,赵艳明,等.人参皂苷佐治晚期胃癌效果观察[J].临床合理用药杂志,2015,8(16):70-71.

[23] 周奕阳,李树芳.人参多糖联合化疗对中晚期消化道肿瘤患者疗效和免疫功能指标的影响[J].实用临床医药杂志,2016,20(23):36-39.

Memo